% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Habes:153378,
author = {Habes, Mohamad and Grothe, Michel J and Tunc, Birkan and
McMillan, Corey and Wolk, David A and Davatzikos, Christos},
title = {{D}isentangling {H}eterogeneity in {A}lzheimer's {D}isease
and {R}elated {D}ementias {U}sing {D}ata-{D}riven
{M}ethods.},
journal = {Biological psychiatry},
volume = {88},
number = {1},
issn = {0006-3223},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DZNE-2020-01375},
pages = {70 - 82},
year = {2020},
abstract = {Brain aging is a complex process that includes atrophy,
vascular injury, and a variety of age-associated
neurodegenerative pathologies, together determining an
individual's course of cognitive decline. While Alzheimer's
disease and related dementias contribute to the
heterogeneity of brain aging, these conditions themselves
are also heterogeneous in their clinical presentation,
progression, and pattern of neural injury. We reviewed
studies that leveraged data-driven approaches to examining
heterogeneity in Alzheimer's disease and related dementias,
with a principal focus on neuroimaging studies exploring
subtypes of regional neurodegeneration patterns. Over the
past decade, the steadily increasing wealth of clinical,
neuroimaging, and molecular biomarker information collected
within large-scale observational cohort studies has allowed
for a richer understanding of the variability of disease
expression within the aging and Alzheimer's disease and
related dementias continuum. Moreover, the availability of
these large-scale datasets has supported the development and
increasing application of clustering techniques for studying
disease heterogeneity in a data-driven manner. In
particular, data-driven studies have led to new discoveries
of previously unappreciated disease subtypes characterized
by distinct neuroimaging patterns of regional
neurodegeneration, which are paralleled by heterogeneous
profiles of pathological, clinical, and molecular biomarker
characteristics. Incorporating these findings into novel
frameworks for more differentiated disease stratification
holds great promise for improving individualized diagnosis
and prognosis of expected clinical progression, and provides
opportunities for development of precision medicine
approaches for therapeutic intervention. We conclude with an
account of the principal challenges associated with
data-driven heterogeneity analyses and outline avenues for
future developments in the field.},
subtyp = {Review Article},
keywords = {Alzheimer Disease: diagnostic imaging / Alzheimer Disease:
pathology / Atrophy: pathology / Brain: diagnostic imaging /
Brain: pathology / Cognitive Dysfunction: pathology / Humans
/ Neuroimaging},
cin = {Rostock / Greifswald common / AG Teipel},
ddc = {610},
cid = {I:(DE-2719)6000017 / I:(DE-2719)1510100},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32201044},
pmc = {pmc:PMC7305953},
doi = {10.1016/j.biopsych.2020.01.016},
url = {https://pub.dzne.de/record/153378},
}